MD Biosciences

02/26/2026

We’re proud to share that MD Biosciences is now accredited by AAALAC International.

AAALAC accreditation is a globally recognized mark of excellence in animal care and goes beyond regulatory compliance.

For our partners, this means:

✔ Independent validation of our animal care program
✔ Stronger study credibility and data reliability
✔ Reduced regulatory risk
✔ Confidence that research is conducted responsibly and ethically

High-quality science starts with high standards.
This milestone reinforces the rigor, responsibility, and excellence we bring to every program.

We’re incredibly proud of our team for reaching this milestone and grateful to the sponsors who trust us with their programs.

02/18/2026

Curious about large animal models? Learn how pigs provide more clinically relevant data than rodents in preclinical research for CNS, pain, and wound healing. 🐖

Download the full paper here: https://hubs.la/Q042Kffw0

02/10/2026

🔍 Advanced AI tools are transforming preclinical wound healing research. DeePathology’s AI-based quantitative histopathology identified and measured key healing markers in a Göttingen minipig burn model.

Download the full posters here, presented at the EWMA conference: https://hubs.la/Q03Vst-y0

02/05/2026

In many programs, early-stage data is strong:
– Target engagement is demonstrated
– Efficacy is shown in rodent models
– Initial safety assessments appear acceptable

As programs advance, predictability often decreases because key translational assumptions have not yet been addressed.

Download the Translational Failure Map here: https://hubs.la/Q03_q14v0

01/27/2026

Most preclinical programs don’t fail because the science was wrong.

Predictability is often lost later because key translational assumptions haven’t been evaluated early enough.

We mapped where this happens most often across development programs, and why it’s difficult to detect early.

Download the Translational Failure Map here: https://hubs.la/Q03_pN9K0

01/21/2026

From acute to chronic inflammation, including rheumatoid arthritis and osteoarthritis, our translational models measure immune activation, tissue changes, and therapeutic effects with clinically relevant endpoints. Explore our resources on inflammatory models here:

https://hubs.la/Q03VrcdB0

A range of preclinical inflammatory pain models from acute inflammatory pain to chronic pain associated with arthritic conditions. Preclinical CRO

01/13/2026

Join us at the Non-Opioid Pain Summit! We’re eager to connect with experts advancing non-opioid pain management and share how our preclinical models support this important research.

Reach out to set up a meeting with our team: https://hubs.la/Q03SRP2y0

01/06/2026

We are excited to introduce new models and cutting-edge tools designed to accelerate your research in 2026. From advanced large-animal studies to refined biomarker detection methods, our innovative solutions are tailored to help you break new ground. Read our 2026 service catalog here:
https://hubs.la/Q03STJJJ0

Neuroscience Discovery Services Catalog

12/09/2025

Advancing preclinical research requires models that reflect real-world diversity. Learn about case studies in our whitepaper that strengthen translational relevance.

📄https://hubs.la/Q03V5gGP0

11/19/2025

Final day at SfN! 🧠 We’ve had a great week connecting with the neuroscience community. If you’re still here, swing by booth 820 before the day ends.

11/18/2025

A highlight from yesterday at SFN: Dr. Shlomi Golan presented on a new neurodegenerative mouse model, co-authored with Dr Sigal Meilin, Dr. Avital Schauder, and Dr. Stephanie Oren. 🔬

11/17/2025

👋 Hello from SfN 2025! We’re presenting our work on Spinal Cord Injury right now. Come stop by PSTR164 (H4)!